Literature DB >> 3286743

Lack of gonadotropic response to pulsatile gonadotropin-releasing hormone in isolated hypogonadotropic hypogonadism associated to congenital adrenal hypoplasia.

P Bovet1, M J Reymond, F Rey, F Gomez.   

Abstract

Congenital adrenal hypoplasia (AH) is a rare condition, known to be associated with isolated hypogonadotropic hypogonadism (IHH). Three studies have reported attempts to stimulate gonadotropin secretion with pulsatile gonadotropin-releasing hormone (GnRH) in a total of 4 patients presenting such a syndrome, with conflicting results. In the present study, one patient with idiopathic IHH and AH was treated with pulsatile sc GnRH--doses ranging from 2.5 to 10.0 micrograms/pulse, every 90 min--during 8 weeks in an attempt to induce puberty. The prepubertal basal plasma levels of LH, FSH and testosterone, and saliva testosterone levels remained unaltered throughout treatment, at all doses of GnRH tested. The gonadotropin response to an acute iv GnRH administration (0.1 mg) also remained at the prepubertal level after pulsatile GnRH treatment. No circulating anti-GnRH antibodies were detected. The absence of gonadotropic response to exogenous pulsatile GnRH suggests that the IHH of patients with AH is due to an abnormal pituitary function rather than to a lack of endogenous GnRH.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3286743     DOI: 10.1007/BF03350135

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

1.  Long-term administration of gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism. A model for studies of the hormone's physiologic effects.

Authors:  D I Spratt; J S Finkelstein; L S O'Dea; T M Badger; P N Rao; J D Campbell; W F Crowley
Journal:  Ann Intern Med       Date:  1986-12       Impact factor: 25.391

Review 2.  Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone.

Authors:  N Santoro; M Filicori; W F Crowley
Journal:  Endocr Rev       Date:  1986-02       Impact factor: 19.871

3.  Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects.

Authors:  M Sakakura; K Takebe; S Nakagawa
Journal:  J Clin Endocrinol Metab       Date:  1975-05       Impact factor: 5.958

4.  Gonadotrophin-secretion in adrenocortical insufficiency: impact of glucocorticoid substitution.

Authors:  H Vierhapper; W Waldhäusl; P Nowotny
Journal:  Acta Endocrinol (Copenh)       Date:  1982-12

5.  Failure to induce puberty in a man with X-linked congenital adrenal hypoplasia and hypogonadotropic hypogonadism by pulsatile administration of low-dose gonadotropin-releasing hormone.

Authors:  K Kikuchi; M Kaji; T Momoi; H Mikawa; Y Shigematsu; M Sudo
Journal:  Acta Endocrinol (Copenh)       Date:  1987-01

6.  The changing ratio of bioactive to immunoreactive luteinizing hormone (LH) through puberty principally reflects changing LH radioimmunoassay dose-response characteristics.

Authors:  S Burstein; E Schaff-Blass; J Blass; R L Rosenfield
Journal:  J Clin Endocrinol Metab       Date:  1985-09       Impact factor: 5.958

7.  Contrasting effects of subcutaneous pulsatile GnRH therapy in congenital adrenal hypoplasia and Kallmann's syndrome.

Authors:  D Gordon; H N Cohen; G H Beastall; I D Hay; J A Thomson
Journal:  Clin Endocrinol (Oxf)       Date:  1984-12       Impact factor: 3.478

8.  Repetitive infusion of gonadotropin-releasing hormone distinguishes hypothalamic from pituitary hypogonadism.

Authors:  P J Snyder; R S Rudenstein; D F Gardner; J G Rothman
Journal:  J Clin Endocrinol Metab       Date:  1979-05       Impact factor: 5.958

9.  Hypogonadism in congenital adrenal hypoplasia: evidence for a hypothalamic origin.

Authors:  K Kruse; W G Sippell; K V Schnakenburg
Journal:  J Clin Endocrinol Metab       Date:  1984-01       Impact factor: 5.958

10.  Hypogonadotropic hypogonadism: hormonal responses to low dose pulsatile administration of gonadotropin-releasing hormone.

Authors:  T W Valk; K P Corley; R P Kelch; J C Marshall
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

View more
  4 in total

Review 1.  Hypogonadotropic hypogonadism in subjects with DAX1 mutations.

Authors:  Unmesh Jadhav; Rebecca M Harris; J Larry Jameson
Journal:  Mol Cell Endocrinol       Date:  2011-06-13       Impact factor: 4.102

2.  DAX1 mutations map to putative structural domains in a deduced three-dimensional model.

Authors:  Y H Zhang; W Guo; R L Wagner; B L Huang; L McCabe; E Vilain; T P Burris; K Anyane-Yeboa; A H Burghes; D Chitayat; A E Chudley; M Genel; J M Gertner; G J Klingensmith; S N Levine; J Nakamoto; M I New; R A Pagon; J G Pappas; C A Quigley; I M Rosenthal; J D Baxter; R J Fletterick; E R McCabe
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

3.  Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production.

Authors:  R L Habiby; P Boepple; L Nachtigall; P M Sluss; W F Crowley; J L Jameson
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

4.  Progressive high frequency hearing loss: an additional feature in the syndrome of congenital adrenal hypoplasia and gonadotrophin deficiency.

Authors:  M Zachmann; E Fuchs; A Prader
Journal:  Eur J Pediatr       Date:  1992-03       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.